These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38205615)

  • 41. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
    Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
    Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal.
    Toro A; Schembari E; Fontana EG; Di Saverio S; Di Carlo I
    Langenbecks Arch Surg; 2021 Sep; 406(6):1739-1749. PubMed ID: 34109472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications after removal of totally implanted central venous access devices: A single-center retrospective study.
    Gennequin M; Elmawieh J; Gomas F
    J Vasc Access; 2023 Feb; ():11297298221145740. PubMed ID: 36847159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of Percutaneous Puncture in Insertion of Totally Implantable Venous Access Devices in Pediatric Patients.
    Choi JS; Park KM; Jung S; Hong KC; Jeon YS; Cho SG; Choe YM
    Vasc Specialist Int; 2017 Sep; 33(3):108-111. PubMed ID: 28955700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome Comparison of Totally Implantable Venous Access Device Insertions Between Surgeons and Radiologists in Australia.
    Dastouri D; McSweeney WT; Leaning M; Hendahewa R
    Cureus; 2022 Mar; 14(3):e23244. PubMed ID: 35449615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications.
    Di Carlo I; Cordio S; La Greca G; Privitera G; Russello D; Puleo S; Latteri F
    Arch Surg; 2001 Sep; 136(9):1050-3. PubMed ID: 11529829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
    He J
    J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Totally Implantable Venous-Access Device Infection Causing Hematogenous Prosthetic Joint Infection: A Retrospective Case Series.
    Medina F; Meyssonnier V; Zeller V; Heym B; Ziza JM; Marmor S
    J Bone Jt Infect; 2018; 3(5):241-244. PubMed ID: 30533344
    [No Abstract]   [Full Text] [Related]  

  • 50. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
    Biffi R; De Braud F; Orsi F; Pozzi S; Arnaldi P; Goldhirsch A; Rotmensz N; Robertson C; Bellomi M; Andreoni B
    Cancer; 2001 Sep; 92(5):1204-12. PubMed ID: 11571734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
    Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chinese expert consensus on the nursing management of the totally implantable venous access device.
    Xu Y; Fei XY; Xue YH; Wang XM; Wang XY; Zheng YT; Chen K; He JJ; Ren XH; Pan L; Wang L; Qian D; Li WF; Liang Y; Fang Y; Huang XF; Li CH; Chen DP; Wang Y; Wen LH; Zhang YH; Zheng Y; Song H; Lin YC; Zhang Q; Yang RM; Wang ZM
    J Cancer Res Ther; 2022 Sep; 18(5):1231-1240. PubMed ID: 36204867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.
    Royle TJ; Davies RE; Gannon MX
    Ann R Coll Surg Engl; 2008 Nov; 90(8):679-84. PubMed ID: 18990281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma.
    Aribas BK; Yildiz F; Uylar T; Tiken R; Aydin H; Akdulum I; Seber T; Caglar E; Savran B; Aribas O
    J Vasc Access; 2021 Nov; ():11297298211059263. PubMed ID: 34796758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case report: Extravascular catheter migration in a child: A rare complication of the totally implantable venous access device.
    Lu X; Ren Y; Wan H; Xu Q; Duan S
    Medicine (Baltimore); 2023 Feb; 102(8):e32710. PubMed ID: 36827053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of complications after closure of totally implantable venous access devices with non-absorbable suture and n-butyl-2-cyanoacrylate (NBCA) skin adhesive: Propensity score matching analysis.
    Lee SB; Kwon LM; Song KS; Do YS; Park JH; Kim BJ
    J Vasc Access; 2023 Aug; ():11297298231193525. PubMed ID: 37615157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.